Nipah Virus Cases in Asia Increase Pressure to Develop a Vaccine

On Jan. 26, 2026, the government of India confirmed two cases of Nipah virus (NiV) infection in its state of West Bengal. Both cases involved health care workers in a hospital in the district of North 24 Parganas. One of the individuals died after being hospitalized on Jan. 28. Contact tracing linked a total of […]
Nursing Home Residents Routinely Given Vaccines Rarely Represented in Clinical Trials

According to researchers at the University of Aberdeen in Scotland, people living in older care homes have been largely excluded from vaccine trials, despite being among the groups most likely to receive vaccines, especially during public health emergencies. Researchers say this mismatch has limited the evidence available on how vaccines perform in care nursing home […]
Florida Senate Advances Bill Allowing Vaccine Manufacturers to Be Sued in State Court

Florida lawmakers are moving legislation that would allow individuals injured by vaccines to sue manufacturers in Florida state courts. The bill passed a Senate committee with a 5-3 vote in January and is advancing through the legislative process.1 If passed, this legislation would mark a departure from decades of product liability immunity that has largely […]
AAP Issues Its Own Recommended Childhood Vaccine Schedule

The American Academy of Pediatrics (AAP) has released its own recommended childhood vaccine guidance, breaking with updated recommendations issued earlier this month by the U.S. Centers for Disease Control and Prevention (CDC).1 On Jan. 6, 2026, the CDC formally updated the U.S. childhood vaccination schedule, introducing changes as to how vaccines are categorized and recommended. […]
Novavax Signs Licensing Agreement With Pfizer for Vaccine Adjuvant Technology

Novavax, Inc. and Pfizer, Inc. have signed a licensing arrangement allowing Pfizer access to Novavax’s Matrix-M adjuvant technology to boost immune response to vaccines. The agreement will allow for use in vaccines targeting up to two infectious diseases.1 Novavax’s Matrix-M technology is an aluminum-free adjuvant designed to enhance the immune response in protein-based vaccines such […]
United States Out of the World Health Organization

One of the first things President Trump did on the first day of his second term in office was sign an Executive Order giving notice that the United States would withdraw from membership in the World Health Organization (WHO). The move, which came just hours after his inauguration on Jan. 20, 2025, had been expected.1 […]
